Structure-based identification and neutralization mechanism of tyrosine sulfate mimetics that inhibit HIV-1 entry

ACS Chemical Biology

Volumn 6, Issue 10, 2011, Pages 1069-1077

  Acharya, Priyamvada ^a   Dogo Isonagie, Cajetan ^b   Lalonde, Judith M ^c   Lam, Son N ^b   Leslie, George J ^d   Louder, Mark K ^a   Frye, Leah L ^e   Debnath, Asim K ^f   Greenwood, Jeremy R ^e   Luongo, Timothy S ^a   Martin, Loïc ^g   Watts, K Shawn ^e   Hoxie, James A ^d   Mascola, John R ^a   Bewley, Carole A ^b   Kwong, Peter D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c BRYN MAWR COLLEGE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e SCHRÖDINGER INC   (United States)

^f NEW YORK BLOOD CENTER   (United States)

^g SERVICE DE CHIMIE BIOORGANIQUE ET DE MARQUAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD4 ANTIGEN; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR CCR5; ENFUVIRTIDE; GLYCOPROTEIN GP 120; MARAVIROC; TYROSINE SULFATE; VIRUS GLYCOPROTEIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; COMPUTER MODEL; DRUG STRUCTURE; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SURFACE PLASMON RESONANCE; VIRUS CELL INTERACTION; VIRUS NEUTRALIZATION; X RAY CRYSTALLOGRAPHY;

ANTI-HIV AGENTS; ANTIGENS, CD4; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; MODELS, MOLECULAR; TYROSINE; VIRUS INTERNALIZATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80055005739     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb200068b     Document Type: Article

References (44)

1. Grant, P. M. and Zolopa, A. R. (2010) Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance Curr. Opin. Invest. Drugs 11, 901-910
2. Qian, K., Morris-Natschke, S. L., and Lee, K. H. (2009) HIV entry inhibitors and their potential in HIV therapy Med. Res. Rev. 29, 369-393
3. Chen, B., Vogan, E. M., Gong, H. Y., Skehel, J. J., Wiley, D. C., and Harrison, S. C. (2005) Structure of an unliganded simian immunodeficiency virus gp120 core Nature 433, 834-841 (Pubitemid 40314887)
4. Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., and Hendrickson, W. A. (1998) Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody Nature 393, 648-659 (Pubitemid 28289647)
5. Rizzuto, C. D., Wyatt, R., Hernandez-Ramos, N., Sun, Y., Kwong, P. D., Hendrickson, W. A., and Sodroski, J. (1998) A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding Science 280, 1949-1953 (Pubitemid 28299405)
6. Berger, E. A., Murphy, P. M., and Farber, J. M. (1999) Chemokine receptors as HIV-1 co-receptors: Roles in viral entry, tropism, and disease Annu. Rev. Immunol. 17, 657-700 (Pubitemid 29241137)
7. Matthews, T., Salgo, M., Greenberg, M., Chung, J., DeMasi, R., and Bolognesi, D. (2004) Enfuvirtide: The first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes Nat. Rev. Drug Discovery 3, 215-225 (Pubitemid 38379988)
8. Dorr, P., Westby, M., Dobbs, S., Griffin, P., Irvine, B., Macartney, M., Mori, J., Rickett, G., Smith-Burchnell, C., Napier, C., Webster, R., Armour, D., Price, D., Stammen, B., Wood, A., and Perros, M. (2005) Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity Antimicrob. Agents Chemother. 49, 4721-4732 (Pubitemid 41552605)
9. Huang, Y. X., Paxton, W. A., Wolinsky, S. M., Neumann, A. U., Zhang, L. Q., He, T., Kang, S., Ceradini, D., Jin, Z. Q., Yazdanbakhsh, K., Kunstman, K., Erickson, D., Dragon, E., Landau, N. R., Phair, J., Ho, D. D., and Koup, R. A. (1996) The role of a mutant CCR5 allele in HIV-1 transmission and disease progression Nat. Med. 2, 1240-1243 (Pubitemid 26375409)
10. Cormier, E. G., Persuh, M., Thompson, D. A. D., Lin, S. W., Sakmar, T. P., Olson, W. C., and Dragic, T. (2000) Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120 Proc. Natl. Acad. Sci. U.S.A. 97, 5762-5767 (Pubitemid 30367472)
11. Cormier, E. G. and Dragic, T. (2002) The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 co-receptor J. Virol. 76, 8953-8957 (Pubitemid 34864089)
12. Huang, C. C., Lam, S. N., Acharya, P., Tang, M., Xiang, S. H., Hussan, S. S., Stanfield, R. L., Robinson, J., Sodroski, J., Wilson, I. A., Wyatt, R., Bewley, C. A., and Kwong, P. D. (2007) Structures of the CCR5 N terminus and of a tyrosine sulfated antibody with HIV-1 gp120 and CD4 Science 317, 1930-1934 (Pubitemid 47509439)
13. Huang, C. C., Venturi, M., Majeed, S., Moore, M. J., Phogat, S., Zhang, M. Y., Dimitrov, D. S., Hendrickson, W. A., Robinson, J., Sodroski, J., Wyatt, R., Choe, H., Farzan, M., and Kwong, P. D. (2004) Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 co-receptor-binding site on gp120 Proc. Natl. Acad. Sci. U.S.A. 101, 2706-2711 (Pubitemid 38327675)
14. Choe, H., Li, W., Wright, P. L., Vasilieva, N., Venturi, M., Huang, C. C., Grundner, C., Dorfman, T., Zwick, M. B., Wang, L., Rosenberg, E. S., Kwong, P. D., Burton, D. R., Robinson, J. E., Sodroski, J. G., and Farzan, M. (2003) Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120 Cell 114, 161-170 (Pubitemid 36936910)
15. Xiang, S. H., Farzan, M., Si, Z., Madani, N., Wang, L., Rosenberg, E., Robinson, J., and Sodroski, J. (2005) Functional mimicry of a human immunodeficiency virus type 1 co-receptor by a neutralizing monoclonal antibody J. Virol. 79, 6068-6077 (Pubitemid 40617212)
16. Kehoe, J. W. and Bertozzi, C. R. (2000) Tyrosine sulfation: a modulator of extracellular protein-protein interactions Chem. Biol. 7, R57-R61
17. Gunning, P. T., Glenn, M. P., Siddiquee, K. A. Z., Katt, W. P., Masson, E., Sebti, S. M., Turkson, J., and Hamilton, A. D. (2008) Targeting protein-protein interactions: Suppression of Stat3 dimerization with rationally designed small-molecule, nonpeptidic SH2 domain binders ChemBioChem 9, 2800-2803
18. Panigrahi, K., Eggen, M., Maeng, J. H., Shen, Q. R., and Berkowitz, D. B. (2009) The alpha,alpha-difluorinated phosphonate L-pSer-analogue: An accessible chemical tool for studying kinase-dependent signal transduction Chem. Biol. 16, 928-936
19. Sun, J. P., Wu, L., Fedorov, A. A., Almo, S. C., and Zhang, Z. Y. (2003) Crystal structure of the Yersinia protein-tyrosine phosphatase YopH complexed with a specific small molecule inhibitor J. Biol. Chem. 278, 33392-33399 (Pubitemid 37055792)
20. Irwin, J. J. and Shoichet, B. K. (2005) ZINC-A free database of commercially available compounds for virtual screening J. Chem. Inf. Model. 45, 177-182 (Pubitemid 40736970)
21. Rush, T. S., 3rd, Grant, J. A., Mosyak, L., and Nicholls, A. (2005) A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction J. Med. Chem. 48, 1489-1495 (Pubitemid 40364556)
22. Jones, G., Willett, P., Glen, R. C., Leach, A. R., and Taylor, R. (1997) Development and validation of a genetic algorithm for flexible docking J. Mol. Biol. 267, 727-748 (Pubitemid 27170693)
23. Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., and Banks, J. L. (2004) Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening J. Med. Chem. 47, 1750-1759 (Pubitemid 38380918)
24. Cormier, E. G., Persuh, M., Thompson, D. A., Lin, S. W., Sakmar, T. P., Olson, W. C., and Dragic, T. (2000) Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120 Proc. Natl. Acad. Sci. U.S.A. 97, 5762-5767 (Pubitemid 30367472)
25. Lam, S. N., Acharya, P., Wyatt, R., Kwong, P. D., and Bewley, C. A. (2008) Tyrosine sulfate isosteres of CCR5 N-terminus as tools for studying HIV-1 entry Bioorg. Med. Chem. 16, 10113-10120
26. Van Herrewege, Y., Morellato, L., Descours, A., Aerts, L., Michiels, J., Heyndrickx, L., Martin, L., and Vanham, G. (2008) CD4 mimetic miniproteins: potent anti-HIV compounds with promising activity as microbicides J. Antimicrob. Chemother. 61, 818-826 (Pubitemid 351436193)
27. Huang, C. C., Stricher, F., Martin, L., Decker, J. M., Majeed, S., Barthe, P., Hendrickson, W. A., Robinson, J., Roumestand, C., Sodroski, J., Wyatt, R., Shaw, G. M., Vita, C., and Kwong, P. D. (2005) Scorpion-toxin mimics of CD4 in complex with human immunodeficiency virus gp120: Crystal structures, molecular mimicry, and neutralization breadth Structure 13, 755-768 (Pubitemid 40704664)
28. Martin, L., Stricher, F., Misse, D., Sironi, F., Pugniere, M., Barthe, P., Prado-Gotor, R., Freulon, I., Magne, X., Roumestand, C., Menez, A., Lusso, P., Veas, F., and Vita, C. (2003) Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes Nat. Biotechnol. 21, 71-76 (Pubitemid 36055830)
29. Stricher, F., Huang, C. C., Descours, A., Duquesnoy, S., Combes, O., Decker, J. M., Do Kwon, Y., Lusso, P., Shaw, G. M., Vita, C., Kwong, P. D., and Martin, L. (2008) Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein J. Mol. Biol. 382, 510-524
30. Decker, J. M., Bibollet-Ruche, F., Wei, X., Wang, S., Levy, D. N., Wang, W., Delaporte, E., Peeters, M., Derdeyn, C. A., Allen, S., Hunter, E., Saag, M. S., Hoxie, J. A., Hahn, B. H., Kwong, P. D., Robinson, J. E., and Shaw, G. M. (2005) Antigenic conservation and immunogenicity of the HIV co-receptor binding site J. Exp. Med. 201, 1407-1419 (Pubitemid 40664085)
31. Madani, N., Schon, A., Princiotto, A. M., Lalonde, J. M., Courter, J. R., Soeta, T., Ng, D., Wang, L., Brower, E. T., Xiang, S. H., Kwon, Y. D., Huang, C. C., Wyatt, R., Kwong, P. D., Freire, E., Smith, A. B., 3rd, and Sodroski, J. (2008) Small-molecule CD4 mimics interact with a highly conserved pocket on HIV-1 gp120 Structure 16, 1689-1701
32. Wu, X., Sambor, A., Nason, M. C., Yang, Z. Y., Wu, L., Zolla-Pazner, S., Nabel, G. J., and Mascola, J. R. (2008) Soluble CD4 broadens neutralization of V3-directed monoclonal antibodies and guinea pig vaccine sera against HIV-1 subtype B and C reference viruses Virology 380, 285-295
33. Kolchinsky, P., Kiprilov, E., Bartley, P., Rubinstein, R., and Sodroski, J. (2001) Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops J. Virol. 75, 3435-3443 (Pubitemid 32225906)
34. Li, Y., Cleveland, B., Klots, I., Travis, B., Richardson, B. A., Anderson, D., Montefiori, D., Polacino, P., and Hu, S. L. (2008) Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses J. Virol. 82, 638-651
35. Leslie, G. J., Acharya, P., Haggarty, B., Jordan, A., Romano, J., Kwong, P., and Hoxie, J. (2011) Derivation of a dual-tropic HIV-1 isolate that can utilize the co-receptor amino terminus in the absence of extracellular loops, Keystone HIV Pathogenesis Meeting, Whistler, Canada.
36. Labrijn, A. F., Poignard, P., Raja, A., Zwick, M. B., Delgado, K., Franti, M., Binley, J., Vivona, V., Grundner, C., Huang, C. C., Venturi, M., Petropoulos, C. J., Wrin, T., Dimitrov, D. S., Robinson, J., Kwong, P. D., Wyatt, R. T., Sodroski, J., and Burton, D. R. (2003) Access of antibody molecules to the conserved co-receptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1 J. Virol. 77, 10557-10565 (Pubitemid 37129699)
37. Chen, W. Z., Zhu, Z. Y., Feng, Y., and Dimitrov, D. S. (2008) Human domain antibodies to conserved sterically restricted regions on gp120 as exceptionally potent cross-reactive HIV-1 neutralizers Proc. Natl. Acad. Sci. U.S.A. 105, 17121-17126
38. Wyatt, R., Moore, J., Accola, M., Desjardin, E., Robinson, J., and Sodroski, J. (1995) Involvement of the V1/V2 Variable Loop Structure in the exposure of Human-Immunodeficiency-Virus Type-1 Gp120 epitopes induced by receptor-binding J. Virol. 69, 5723-5733
39. Wei, X. P., Decker, J. M., Wang, S. Y., Hui, H. X., Kappes, J. C., Wu, X. Y., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., Komarova, N. L., Nowak, M. A., Hahn, B. H., Kwong, P. D., and Shaw, G. M. (2003) Antibody neutralization and escape by HIV-1 Nature 422, 307-312 (Pubitemid 36378357)
40. Erratum: Nature 423, 197
41. Kwong, P. D., Doyle, M. L., Casper, D. J., Cicala, C., Leavitt, S. A., Majeed, S., Steenbeke, T. D., Venturi, M., Chaiken, I., Fung, M., Katinger, H., Parren, P. W. L. H., Robinson, J., Van Ryk, D., Wang, L. P., Burton, D. R., Freire, E., Wyatt, R., Sodroski, J., Hendrickson, W. A., and Arthos, J. (2002) HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites Nature 420, 678-682 (Pubitemid 36764500)
42. Li, Y. X., Migueles, S. A., Welcher, B., Svehla, K., Phogat, A., Louder, M. K., Wu, X. L., Shaw, G. M., Connors, M., Wyatt, R. T., and Mascola, J. R. (2007) Broad HIV-1 neutralization mediated by CD4-binding site antibodies Nat. Med. 13, 1032-1034 (Pubitemid 47517505)
43. Mirzabekov, T., Bannert, N., Farzan, M., Hofmann, W., Kolchinsky, P., Wu, L. J., Wyatt, R., and Sodroski, J. (1999) Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 co-receptor J. Biol. Chem. 274, 28745-28750
44. Zhao, Q., Ma, L., Jiang, S., Lu, H., Liu, S., He, Y., Strick, N., Neamati, N., and Debnath, A. K. (2005) Identification of N-phenyl-N′-(2,2, 6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4 Virol. 339, 213-225 (Pubitemid 41169789)